Antibodies that bind to and inhibit the acceptance of progranulin sortilina

摘要

The present Invention relates to monoclonal anti sortilina has been found to be useful in Correcting a poor level of progranulin (PGRN).In particular, these Antibodies can be used in the treatment of frontotemporal dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS).